The artificial cell design: nanoparticles - Artificial Cells, Cell Engineering and Therapy - page 111

4.7 Sources of further information and advice

http://www.azonano.com
Gunter Schmid (2004), Nanoparticles: From Theory to Applications, Wiley-
VCH, Weinheim.

4.8 References
Aboubakar M., Puisieux F., Couvreur P., Deyme M. and Vauthier C. (1999), `Study of the
mechanism of insulin encapsulation in poly(isobutylcanoacrylate) nanocapsules
obtained by interficial polymerization', J Biomed. Mater. Res., 47(4): 568±576.
Ai H. and Gao J. (2004), `Size-controlled polyelectrolyte nanocapsules via layer-by-layer
self-assembly', J. Mater. Sci., 39: 1429±1432.
Alakhov V., Klinski E., Li S., Pietrzynski G., Venne A., Batrakova E., Bronitch T. and
Kabanov A. (1999), `Block-copolymer-based formulation of doxorubicin. From cell
screen to clinical trials', Colloids Surf. B Biointerfaces 16: 113±134.
Al-Khouri N. (1984), `Nanocapsules de polyalkylcyanoacrylate. Nouveaux vecteurs de
medicaments. Etude galenique et pharmacocinetique'. These de Doctorat d'Etat,
Universite Paris Sud.
Avgoustakis K. (2004), `Pegylated poly(lactide) and poly(lactide-co-glycolide)
nanoparticles: preparation, properties and possible applications', Drug Delivery,
1(4): 321±333.
Barratt G.M. (2000), `Therapeutic applications of colloidal drug carriers', Pharm. Sci.
Technol. Today 3: 163±171.
Barratt G., Puisieux F., Yu W.P., Foucher C.H. and Devissaguet J.P. (1994), `Anti-
metastatic activity of MDP- L -alanyl-choloesterol incorporated into various types of
nanocapsules', Int. J. Immunopharm., 16: 457±461.
Brasseur E.L., Couvreur P., Kanta B., Deckers-Passau L., Roland M., Deckers C. and
Speiser P. (1980), `Actinomycin D adsorbed on polymethylcyanacrylate
nanoparticles: increase efficiency against an experimental tumor', Eur. J. Cancer,
16: 1441±1445.
Burger K.N.J., Staffhorst R.W.H.M., de Vijlder H.C., Velinova M.J., Bomans P.H.,
Frederik P.M. and de Kruijff B. (2002), `Nanocapsules: lipid-coated aggregates of
cisplatin with high cytotoxicity', Nature Medicine, 8: 81±84.
Chang T.M., Powanda D. and Yu W.P. (2003), `Analysis of polyethylene-glycol-
polylactide nano-dimension artificial red blood cells in maintaining systemic
hemoglobin levels and prevention of methemoglobin formation', Artif. Cells Blood
Substit. Immobil. Biotechnol. 31: 3231±3247.
Chupin V., de Kroon A.I. and de Kruijff B. (2005), `Molecular architecture of
nanocapsules, bilayer-enclosed solid particles of Cisplatin', Cancer Therapy, 3:
131±138.
Damascelli B., Cantu G., Mattavelli F., Tamplenizza P., Bidoli P., Leo E., Dosio F.,
Cerrotta A.M., Di Tolla G., Frigerio L.F., Garbagnati F., Lanocita R., Marchiano
A., Patelli G., Spreafico C., Ticha V., Vespro V. and Zunino F. (2001), `Intraarterial
chemotherapy with polyoxyethylated castor oil freepaclitaxel, incorporated in
albumin nanoparticles (ABI-007): phase II study of patients with squamous cell
carcinoma of the head and neck and anal canal: preliminary evidence of clinical
activity', Cancer, 92: 2592±2602.
Desai N.P., Louie L., Ron N., Magdassi S. and Soo-Shiong P. (2000), `Protein-based